Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers
- PMID: 3149043
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers
Abstract
Basal t-PA antigen concentration, PAI-I activity and fibrinolytic capacity was studied in plasma from 20 healthy teenager girls (age 15.9 +/- 1.3 years) and two groups of older healthy volunteers, consisting of 17 women (age 32 +/- 8 years, group 1) and 35 men (age 34 +/- 8 years, group 2). Basal t-PA antigen concentrations in plasma were found to be highly age-dependent with higher values with increasing age. The teenager girls had significantly lower values compared with the two groups of elderly volunteers. PAI-I levels were significantly higher in plasma from the teenager girls and the fibrinolytic capacity after 15 min of venous occlusion was significantly lower. In this study we also determined the effect of low-dose oral contraceptives (OC) on coagulation and fibrinolysis in the teenager group. Each teenager served as her own control with samples drawn before and on OC after 4 months of use. The coagulation parameters, factor VIII activity, AT III, Protein C and platelet counts were all within reference values before and on OC. The fibrinolytic activity in plasma after venous occlusion (15 min) increased significantly when the teenagers had used OC for 4 months. This phenomenon was explained by significantly decreased PAI levels and also by significantly increased t-PA antigen release from the vessel wall after venous occlusion.
PIP: The effect of high and low-dose oral contraceptives (OCs) on the fibrinolytic system remains controversial, although disturbances in this system are associated with the development of venous thrombosis. It has been suggested that this may be due to either a decreased synthesis of vessel wall tissue plasminogen activator (t-PA) or a defective release of t-PA from the vessel wall. Defective fibrinolysis can also be due to increased concentration of tissue plasminogen activitor inhibitor (PAI-I). This studied utilized new and improved methods for t-PA and PAI-I measurements in plasma to: study basal fibrinolytic activity, basal t-PA antigen concentration, and PAI-I in plasma from teenagers to assess whether these parameters are age-dependent; 2) evaluate the influence of low-dose OCs on the fibrinolytic components; and 3) study possible variations in some coagulation factors. Plasma were obtained from 20 healthy female adolescents (mean age 16 years), 17 health adult women (mean age 32 years) and 35 healthy adult males (mean age 34 years). Basal t-PA antigen concentrations plasma were highly age dependent, with higher values with increasing age. The fibrinolytic capacity was also lower in the younger women, while PAI-I levels were higher. This finding suggests a need for age- and sex-matched controls in studies of the components of fibrinolysis in plasma. 4 months of OC use did not affect coagulation parameters, factor VIII activity, AT III, Protein C, or platelet counts. However, fibrinolytic activity in plasma after venous occlusion (15 minutes) increased significantly in teenagers who used OCs for 4 months. This finding was explained by significantly decreased PAI levels and increased t-PA antigen release from the vessel wall after venous occlusion.
Similar articles
-
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.Dan Med Bull. 2002 Feb;49(1):43-60. Dan Med Bull. 2002. PMID: 11894723 Review.
-
Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.Thromb Haemost. 1995 Sep;74(3):928-32. Thromb Haemost. 1995. PMID: 8571323
-
Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.Thromb Haemost. 1988 Apr 8;59(2):299-303. Thromb Haemost. 1988. PMID: 3133812
-
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.Thromb Haemost. 2000 Jul;84(1):9-14. Thromb Haemost. 2000. PMID: 10928462 Clinical Trial.
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
Cited by
-
[The antibaby pill as a risk factor for thrombosis: are the molecular mechanisms known?].Klin Wochenschr. 1991 May 24;69(8):335-9. doi: 10.1007/BF02115778. Klin Wochenschr. 1991. PMID: 1886397 Review. German.
-
Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysis.J Thromb Thrombolysis. 2022 Feb;53(2):454-466. doi: 10.1007/s11239-021-02556-7. Epub 2021 Aug 31. J Thromb Thrombolysis. 2022. PMID: 34463919
-
Effects of anchoring sutures at diverting ileostomy after rectal cancer surgery on peritoneal adhesion at following ileostomy reversal.Ann Surg Treat Res. 2021 Oct;101(4):214-220. doi: 10.4174/astr.2021.101.4.214. Epub 2021 Oct 1. Ann Surg Treat Res. 2021. PMID: 34692593 Free PMC article.
-
Systemic thrombolytic therapy alone and in combination with mechanical revascularization in acute ischemic stroke in two children.Case Rep Neurol. 2011 Apr 12;3(1):91-6. doi: 10.1159/000327554. Case Rep Neurol. 2011. PMID: 21532986 Free PMC article.
-
Thrombolysis in pediatric stroke study.Stroke. 2015 Mar;46(3):880-5. doi: 10.1161/STROKEAHA.114.008210. Epub 2015 Jan 22. Stroke. 2015. PMID: 25613306 Free PMC article. Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical